AstraZeneca overhauls its drugs distribution

19 April 2007
More news

20 April 2007 | Antony Barton

AstraZeneca has appointed AAH Pharmaceuticals and Unichem to deliver its medicines directly to pharmacies and hospital patients in the UK.

This arrangement replaces its system of supplying medicines indirectly through various wholesalers. It follows the company's review of its supply chain and last month's decision by drugs company Pfizer to sell prescription drugs solely through Unichem.

Dr Rhiannon Rowsell, medical and regulatory affairs director for AstraZeneca, said: "We are taking responsibility for ensuring a modern and simplified supply and delivery service is in place for all pharmacies, dispensing doctors and hospitals, so the right medicine, often for serious conditions, is delivered to the right place, for every patient, every single time."

AstraZeneca plans to introduce the new supply and delivery service in late summer. The commercial arrangements with its customers are being reviewed and the company will continue to consult relevant stakeholders.

The Office of Fair Trading launched a probe into UK medicine distribution earlier this month, which will focus on such changes.


Hounslow, Heathrow /Richmond upon Thames
Competitive salary depending on experience plus generous share award
GBP40000 - GBP50000 per annum + Excellent Benefits Package
Bramwith Consulting
CIPS Knowledge
Find out more with CIPS Knowledge:
  • best practice insights
  • guidance
  • tools and templates